PxWire Archive
2009
April-June 2009, Volume 2, Number 2
This issue features multiple trial updates, including a review of the key findings from a trial of HSV-2 suppression. There's also a discussion of the results of the HPTN 035 microbicide trial (which tested PRO 2000 and BufferGel) and preparations for the upcoming results of MDP 301, also testing PRO 2000 gel. Additionally, this issue provides information on new trials including HVTN 505 (described in this year's first issue of Px Wire), which began screening participants in June, a new trial on intermittent PrEP scheduled to begin in July, and research to test a nipple shield to help prevent HIV transmission during breastfeeding.
January-March 2009, Volume 2, Number 1
Highlights in this issue of Px Wire include a report on data from the Step vaccine trial and animal studies of relevance to the proposed HVTN 505 trial of the NIH Vaccine Research Center DNA-Ad5 combination strategy presented at the Keystone Symposium on HIV prevention--an annual meeting focused on basic and preclinical science. This issue also reviews newly launched trials, lays out this year's upcoming trial milestones, and gives information on ordering the 2009 AVAC report on the prevention research field, to be released in May.
2008
October-December 2008, Volume 1, Number 4
In this year-end issue, you'll find AVAC's take on the year in prevention research, an update on the proposed AIDS vaccine trial HVTN 505, news on the female condom and microbicide trials and, as always, a freshly updated global map of ongoing efficacy and effectiveness trials, and a comprehensive timeline of biomedical HIV prevention efficacy trials.
July-September 2008, Volume 1, Number 3
Highlights in this issue of Px Wire include a discussion of the no-go decision on the proposed PAVE 100 vaccine trial (though the candidate may yet be tested), updates on women's input into male circumcision for HIV prevention, and AVAC's take on indelible moments and themes from the International AIDS Conference in Mexico City in August.
April-June 2008, Volume 1, Number. 2 / Abril--junio 2008, Vol. 1. No. 2 (en español)
Highlights in this issue of Px Wire include an update on the ongoing discussion regarding the proposed PAVE 100 vaccine trial, details on the first microbicide trial in pregnant women, a Mexico City preview, and notes on two recently released resources for the field, AVAC Report 2008: The Search Must Continue and the Global Campaign for Microbicides' Microbicides Essentials online learning tool.
January-March 2008, Volume 1, Number 1
This is the first issue of our new quarterly, Px Wire, which tracks key developments in the field of HIV prevention research, including the launch of new trials, results of ongoing studies, and an up-to-date tally of trials going on worldwide. Px Wire is designed to complement AVAC's other publications and to help advocates stay on top of the ever-changing field of HIV prevention research. It is the first one-stop source for information on the full range of HIV prevention research going on worldwide, including vaccines, microbicides, pre-exposure prophylaxis (PrEP), herpes simplex virus-2 treatment, male circumcision, cervical barrier methods, and partner treatment.
April-June 2009, Volume 2, Number 2
This issue features multiple trial updates, including a review of the key findings from a trial of HSV-2 suppression. There's also a discussion of the results of the HPTN 035 microbicide trial (which tested PRO 2000 and BufferGel) and preparations for the upcoming results of MDP 301, also testing PRO 2000 gel. Additionally, this issue provides information on new trials including HVTN 505 (described in this year's first issue of Px Wire), which began screening participants in June, a new trial on intermittent PrEP scheduled to begin in July, and research to test a nipple shield to help prevent HIV transmission during breastfeeding.
January-March 2009, Volume 2, Number 1
Highlights in this issue of Px Wire include a report on data from the Step vaccine trial and animal studies of relevance to the proposed HVTN 505 trial of the NIH Vaccine Research Center DNA-Ad5 combination strategy presented at the Keystone Symposium on HIV prevention--an annual meeting focused on basic and preclinical science. This issue also reviews newly launched trials, lays out this year's upcoming trial milestones, and gives information on ordering the 2009 AVAC report on the prevention research field, to be released in May.
2008
October-December 2008, Volume 1, Number 4
In this year-end issue, you'll find AVAC's take on the year in prevention research, an update on the proposed AIDS vaccine trial HVTN 505, news on the female condom and microbicide trials and, as always, a freshly updated global map of ongoing efficacy and effectiveness trials, and a comprehensive timeline of biomedical HIV prevention efficacy trials.
July-September 2008, Volume 1, Number 3
Highlights in this issue of Px Wire include a discussion of the no-go decision on the proposed PAVE 100 vaccine trial (though the candidate may yet be tested), updates on women's input into male circumcision for HIV prevention, and AVAC's take on indelible moments and themes from the International AIDS Conference in Mexico City in August.
April-June 2008, Volume 1, Number. 2 / Abril--junio 2008, Vol. 1. No. 2 (en español)
Highlights in this issue of Px Wire include an update on the ongoing discussion regarding the proposed PAVE 100 vaccine trial, details on the first microbicide trial in pregnant women, a Mexico City preview, and notes on two recently released resources for the field, AVAC Report 2008: The Search Must Continue and the Global Campaign for Microbicides' Microbicides Essentials online learning tool.
January-March 2008, Volume 1, Number 1
This is the first issue of our new quarterly, Px Wire, which tracks key developments in the field of HIV prevention research, including the launch of new trials, results of ongoing studies, and an up-to-date tally of trials going on worldwide. Px Wire is designed to complement AVAC's other publications and to help advocates stay on top of the ever-changing field of HIV prevention research. It is the first one-stop source for information on the full range of HIV prevention research going on worldwide, including vaccines, microbicides, pre-exposure prophylaxis (PrEP), herpes simplex virus-2 treatment, male circumcision, cervical barrier methods, and partner treatment.